Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia Following Initial Treatment, The ERASE Study (A MyeloMATCH Treatment Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
PETHEMA Foundation
Institute of Hematology & Blood Diseases Hospital, China
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Ohio State University Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Jonsson Comprehensive Cancer Center
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
University of Miami
Hoosier Cancer Research Network
University of Manchester
The First Affiliated Hospital of Soochow University
French Innovative Leukemia Organisation
Children's Hospital of Philadelphia
M.D. Anderson Cancer Center
The Methodist Hospital Research Institute
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
Sichuan Baili Pharmaceutical Co., Ltd.
ASL Lecce
University of Chicago
M.D. Anderson Cancer Center
Baylor College of Medicine
Amgen
Baylor College of Medicine
Peking University People's Hospital
Baptist Health South Florida
Dana-Farber Cancer Institute
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
PETHEMA Foundation
Children's Oncology Group
Cancer Research UK
Tianjin First Central Hospital
University of Iowa
The First Affiliated Hospital of Soochow University
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
University of Rochester
Ascentage Pharma Group Inc.
Ege University
Nantes University Hospital
M.D. Anderson Cancer Center
Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud - IDCBIS
Washington University School of Medicine